Cleared Traditional

K042157 - DAPTOMYCIN ANTIMICROBIAL SUSCEPTIBILITY...

K042157 is the FDA 510(k) clearance for DAPTOMYCIN ANTIMICROBIAL SUSCEPTIBILITY... by Oxoid , Ltd.. It is a Class 2 Microbiology device (product code JTN) cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K042157 · Oxoid , Ltd. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2004
Decision
35d
Days
Class 2
Risk

K042157 is an FDA 510(k) clearance for the DAPTOMYCIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC. Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Oxoid , Ltd. (Basingstoke, GB). The FDA issued a Cleared decision on September 14, 2004 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Oxoid , Ltd. devices

Submission Details

510(k) Number K042157 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 10, 2004
Decision Date September 14, 2004
Days to Decision 35 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 102d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 282
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K042157.
TIGECYCLINE 15UG BBL SENSI-DISC
K052853 · Becton, Dickinson & CO · Nov 2005
TELITHROMYCIN 15UG BBL SENSI-DISC
K052876 · Becton, Dickinson & CO · Nov 2005
GEMIFLOXACIN, 5UG BBL SENSI-DISC
K050062 · Becton, Dickinson & CO · Feb 2005
ERTAPENEM 10UG BBL SENSI-DISC
K020842 · Becton, Dickinson & CO · May 2002
HARDYDISK NOVOBIOCIN, 30MCG, MODEL Z883
K011384 · Hardy Diagnostics · Jun 2001
HARDKYDISK NEOMYCIN, 30 MCG
K011385 · Hardy Diagnostics · May 2001